-
Expert’s Insight | Dr. Chenghai Liu: ” Dual Antagonism” Strategy Assists in the Full Course Management of Chronic Liver Disease
Improving the prognosis of chronic viral hepatitis is a crucial goal in clinical treatment. Chronic hepatitis B (CHB) has a wide incidence, and its severe harm mainly stems from the progression from liver fibrosis to cirrhosis, leading to decompensated cirrhosis and liver cancer, seriously threatening the patient’s life and health. Therefore, reversing early cirrhosis is…
-
Annual Meeting Exclusive Interview | Dr. Xiong Ma: Comparing International and Chinese Guidelines for Autoimmune Hepatitis Treatment
Autoimmune Hepatitis (AIH) is an acute or chronic liver inflammatory disease caused by unknown immune abnormalities. Without timely treatment, it can progress to liver cirrhosis, liver failure, and even lead to death. The diagnostic scoring systems and criteria proposed in current domestic and international guidelines have significantly advanced the diagnosis and treatment of AIH. Moreover,…
-
“Year-EndAnnual Review | Professor Jia JidongDr. Jidong Jia: Latest Developments in the Clinical Diagnosis and Treatment of Primary Biliary Cholangitis”
Primary Biliary Cholangitis (PBC) is an autoimmune liver disease that predominantly affects middle-aged women. The exact cause and mechanism of its onset are not yet fully understood. It is thought to be related to genetic factors and their interaction with environmental factors leading to immune dysregulation. Currently, there are few effective medications available for clinical…
-
“Annual Review | Professor Yang MingDr. Ming Yang: Latest Developments in Systemic Treatment of Biliary Tract Cancer”
In the field of biliary tract cancer (BTC) treatment, significant advancements have been made recently. BTC is a highly heterogeneous group of malignancies originating from the epithelium of the bile ducts, presenting challenges in treatment and typically leading to short survival periods for patients. Traditionally, the primary treatment for advanced BTC has been chemotherapy. However,…
-
CDL (co-management of diabetes-liver diseases strategy) Literature Review – January 2024, Issue 12
Diabetes and liver disease are prevalent chronic conditions in China, with interconnections in terms of pathogenesis, clinical manifestations, diagnostic and therapeutic targets, making their combined management essential for alleviating the burden of these diseases. In support of the development of diabetes and liver disease co-management initiatives in China, this publication Hepatology Digest, collaborates with the…
-
Annual Review |Dr. Haitao Zhao: Molecular Characteristics, Diagnosis and Treatment, and New Drug Progress and Exploration Prospects in Biliary Tract Cancer
Editor’s Note: Although biliary tract cancer (BTC) is relatively rare, it has a higher incidence in the Southeast Asian population, with 50% of patients already in advanced stages at diagnosis and a survival period of less than one year. Its impact cannot be ignored. In 2023, China saw the approval and market launch of the…
-
Annual Review | Dr. Guiqiang Wang: Pursuing Clinical Cure for Hepatitis B, Focusing on Advances in New Drug Development
Antiviral therapy is the primary treatment strategy for chronic hepatitis B (CHB), aiming to inhibit HBV replication, alleviate liver cell inflammation and fibrosis, and reduce the risk of liver failure, decompensated cirrhosis, and hepatocellular carcinoma (HCC). However, there is currently no treatment that can completely clear covalently closed circular DNA (cccDNA) in infected liver cells,…
-
Anticoagulant Therapy for Acute Pancreatitis-Related Splanchnic Vein Thrombosis
The “Hepatology Digest – Liver Vascular Disease Column” is an academic column initiated by Dr. Qixing Shun from the Department of Gastroenterology, Northern Theater General Hospital, in response to the invitation of the editorial department of “Hepatology Digest”. It regularly collects and organizes research progress in the field of hepatic vascular diseases. Every two weeks…
Connecting Medical Expertise through Media